(5S,8R)-HBV-IN-10
(5S,8R)-HBV-IN-10 is an enantiomer of compound 6 (WO2021204258A1). Compound 6 is a hepatitis B surface antigen (HBsAg) inhibitor (0.001 μM50 ≤0.05 μM). From patent WO2021204258A1, compound 6.
Référence interne:
cell25sk19633